Skip to main navigation Skip to search Skip to main content

Ribociclib in Kombination mit endokriner Therapie verbessert Überleben von prä-/perimenopausalen Mammakarzinom-Patientinnen

Translated title of the contribution: Ribociclib in combination with endocrine therapy improves overall survival of pre-/perimenopausal breast cancer patients

David Krug*, Alexander Fabian, Jürgen Dunst

*Corresponding author for this work
Translated title of the contributionRibociclib in combination with endocrine therapy improves overall survival of pre-/perimenopausal breast cancer patients
Original languageGerman
JournalStrahlentherapie und Onkologie
Volume196
Issue number3
Pages (from-to)286-288
Number of pages3
ISSN0179-7158
DOIs
Publication statusPublished - 01.03.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this